Deborah Weitzman's most recent trade in Cardinal Health, Inc. was a trade of 632 Common Shares done at an average price of $122.2 . Disclosure was reported to the exchange on Dec. 2, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cardinal Health, Inc. | Deborah Weitzman | CEO, PSS Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.24 per share. | 02 Dec 2024 | 632 | 49,129 (0%) | 0% | 122.2 | 77,256 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, PSS Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 13,530 | 52,102 (0%) | 0% | 0 | Common Shares | |
Cardinal Health, Inc. | Deborah Weitzman | CEO, PSS Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 106.36 per share. | 15 Aug 2024 | 9,918 | 38,572 (0%) | 0% | 106.4 | 1,054,878 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, PSS Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.91 per share. | 15 Aug 2024 | 2,341 | 49,761 (0%) | 0% | 107.9 | 252,617 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, PSS Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 13,926 | 48,490 (0%) | 0% | 0 | Common Shares | |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 107.08 per share. | 01 Dec 2023 | 638 | 34,564 (0%) | 0% | 107.1 | 68,317 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Sale of securities on an exchange or to another person at price $ 106.31 per share. | 27 Nov 2023 | 36,642 | 35,202 (0%) | 0% | 106.3 | 3,895,411 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.43 per share. | 27 Nov 2023 | 15,373 | 71,844 (0%) | 0% | 66.4 | 1,021,228 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2023 | 15,373 | 0 | - | - | Employee Stock Option (right to buy) | |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.19 per share. | 27 Nov 2023 | 6,279 | 56,471 (0%) | 0% | 83.2 | 522,350 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2023 | 6,279 | 0 | - | - | Employee Stock Option (right to buy) | |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.27 per share. | 27 Nov 2023 | 5,990 | 50,192 (0%) | 0% | 84.3 | 504,777 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Nov 2023 | 5,990 | 0 | - | - | Employee Stock Option (right to buy) | |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.43 per share. | 28 Aug 2023 | 6,712 | 50,914 (0%) | 0% | 71.4 | 479,438 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2023 | 6,712 | 0 | - | - | Employee Stock Option (right to buy) | |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Sale of securities on an exchange or to another person at price $ 89.81 per share. | 28 Aug 2023 | 6,712 | 44,202 (0%) | 0% | 89.8 | 602,805 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 15,487 | 44,202 (0%) | 0% | 0 | Common Shares | |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.99 per share. | 15 Aug 2023 | 10,966 | 28,715 (0%) | 0% | 93.0 | 1,019,728 | Common Shares |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2023 | 12,760 | 39,681 (0%) | 0% | 0 | Common Shares | |
Cardinal Health, Inc. | Deborah Weitzman | CEO, Pharmaceutical Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.17 per share. | 01 Dec 2022 | 380 | 26,921 (0%) | 0% | 80.2 | 30,465 | Common Shares |